S Kashiwagi

1.0k total citations
36 papers, 832 citations indexed

About

S Kashiwagi is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, S Kashiwagi has authored 36 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 17 papers in Immunology and 13 papers in Hepatology. Recurrent topics in S Kashiwagi's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (12 papers) and Influenza Virus Research Studies (6 papers). S Kashiwagi is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (12 papers) and Influenza Virus Research Studies (6 papers). S Kashiwagi collaborates with scholars based in Japan. S Kashiwagi's co-authors include Hideyuki Ikematsu, Wataru Kajiyama, Hideyuki Nomura, K. Okochi, Yasuhiro Kishihara, Jun Hayashi, Norio Iwaki, Nobuo Hirotsu, Naoki Kawai and Kouzaburo Yamaji and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Epidemiology and The Journal of Infectious Diseases.

In The Last Decade

S Kashiwagi

36 papers receiving 799 citations

Peers

S Kashiwagi
Comparison fields: 5 of 75
  • Epidemiology 443
  • Immunology 361
  • Hepatology 255
  • Agronomy and Crop Science 252
  • Ecology, Evolution, Behavior and Systematics 201
Replace Andrea Mangano with:
Andrea Mangano Argentina
T. H. Lee United States
Maria Alice Freitas Queiroz Brazil
Erica Silberstein United States
M.O.G. Ishak Brazil
Izaura Maria Vieira Cayres Vallinoto Brazil
Filippo Turrini Italy
I. Windsor South Africa
Luke S. Uebelhoer United States
Aurélia F. Porto Brazil
Andrea Mangano Argentina View profile →
Citations per field, relative to S Kashiwagi
S Kashiwagi · 1×
Citations per year, relative to S Kashiwagi
S Kashiwagi · 1×

Countries citing papers authored by S Kashiwagi

Since Specialization
Citations

This map shows the geographic impact of S Kashiwagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Kashiwagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Kashiwagi more than expected).

Fields of papers citing papers by S Kashiwagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Kashiwagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Kashiwagi. The network helps show where S Kashiwagi may publish in the future.

Co-authorship network of co-authors of S Kashiwagi

This figure shows the co-authorship network connecting the top 25 collaborators of S Kashiwagi. A scholar is included among the top collaborators of S Kashiwagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Kashiwagi. S Kashiwagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 138
2 5
3
Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
40
4 28
5 6
6 1
7 2
8 6
9
Transmission of hepatitis C virus by health care workers in a rural area of Japan.
80
10
A preliminary study of retreatment of chronic hepatitis C with interferon.
2
11 4
12 26
13
Effectiveness of relative low-dose interferon treatment for patients with chronic hepatitis C.
2
14 1
15
Hepatitis C virus is a more likely cause of chronic liver disease in the Japanese population than hepatitis B virus.
18
16 1
17
Human lymphoblastoid and fibroblast interferon in the treatment of chronic hepatitis B.
5
18 11
19 11
20
A family study of HBsAg carrier and major histocompatibility antigens.
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026